
BioCellgraft advances strategic commercialization planning for OraFyl™ with its partner Celularity, Inc.
BioCellgraft's recent successful collection of patient cases using OraFyl in dozens of gum and bone related dental procedures positions the product to dominate. NEW YORK, NY, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- OraFyl™, …